-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Production Process of 6-Cyclopropylpyridazin-3-amine in the Chemical Industry: An Overview
6-cyclopropylpyridazin-3-amine (CPA) is an important organic compound that is widely used in various applications, including pharmaceuticals, agrochemicals, and materials science.
The production process of CPA involves several steps, each of which requires careful control and optimization to ensure the quality and purity of the final product.
In this article, we will provide an overview of the production process of CPA in the chemical industry.
Step 1: Synthesis of Nitrosonium Ion
The first step in the production of CPA involves the synthesis of nitrosonium ion (NO+) from nitric acid (HNO3) and a Lewis acid catalyst, such as aluminum chloride (AlCl3).
This reaction is highly exothermic and requires careful temperature control to avoid unwanted side reactions.
The synthesis of NO+ is usually carried out in a well-ventilated area, as it can generate nitrogen oxides (NOx), which are toxic and corrosive.
Step 2: Nitrosonium Ion Transfer to Pyridazine
In the second step, the NO+ ion is transferred to pyridazine (C5H5N3) to form 6-chloropyridazine (C5H5ClN3).
This reaction is carried out in the presence of a coupling agent, such as cesium carbonate (Cs2CO3), and a solvent, such as dimethylformamide (DMF).
The choice of solvent and coupling agent can have a significant impact on the yield and purity of the final product.
Step 3: Demethylation and Decarboxylation
In the third step, 6-chloropyridazine is subjected to demethylation and decarboxylation to form N-chlorosuccinimide (NCS), which is a toxic and corrosive compound.
This reaction involves heating the pyridazine derivative in the presence of a strong acid catalyst, such as sulfuric acid (H2SO4), and a solvent, such as benzene.
The solvent and catalyst used in this step must be selected carefully to minimize the risk of unwanted side reactions and to maximize the yield of the desired product.
Step 4: N-Chlorosuccinimide Hydrolysis
In the fourth step, N-chlorosuccinimide is hydrolyzed in the presence of a strong base, such as sodium hydroxide (NaOH), to form 3-nitro-2-oxindole (NOI).
This reaction requires careful control of the reaction conditions to avoid hydrolysis of the NCS molecule, which can lead to the formation of unwanted side products.
Step 5: Formation of 6-Cyclopropylpyridazin-3-amine
In the final step, 3-nitro-2-oxindole is reduced to form 6-cyclopropylpyridazin-3-amine (CPA) using a reducing agent, such as lithium aluminum hydride (LiAlH4) or hydrogen (H2) in the presence of a solvent, such as acetonitrile or ethanol.
The reduction reaction is usually carried out under an inert gas atmosphere, such as nitrogen or argon, to minimize the risk of unwanted side reactions.
Optimization of the Production Process
The production process of CPA involves several steps that require careful optimization to ensure the quality and purity of the final product.
The choice of solvent, catalyst, and reducing agent can have a significant impact on the yield and purity of the final product.
The reaction conditions, such as temperature, pressure, and stirring rate, must also be carefully controlled to ensure